Tag: array

Posted on

Array BioPharma scores midstage success for asthma drug – FierceBiotech

Array BioPharma scores midstage success for asthma drug
FierceBiotech
Array BioPharma has another asset on deck for a potential partnership. The Boulder, CO-based drug developer has touted upbeat Phase II data for an experimental drug in patients with allergic asthma, and the company ($ARRY) plans to seek a partner to …
Array asthma drug meets main goal in mid-stage studyReuters
Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung …Wall Street Journal
Array Seeks Asthma Drug Partner Following Mid-Stage Study ResultsTheStreet.com
RTT News –Benzinga –Yahoo! News
all 8 news articles »

View full post on asthma – Google News

Posted on

Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung … – Wall Street Journal

Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung …
Wall Street Journal
Secondary efficacy endpoints in the proof-of-concept study were also achieved, including reduced short-acting beta agonist use; asthma control; forced vital capacity improvement; symptom-free days during treatment; and improvement in rhinasthma and …
Array BioPharma: ARRY-502 Meets Primary And Secondary Endpoints In …RTT News
Array Biopharma To Report Top-line Results From ARRY-502 Asthma TrialBenzinga

all 3 news articles »

View full post on asthma – Google News

Posted on

Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal … – MarketWatch (press release)

Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal …
MarketWatch (press release)
In addition, Array initiated new clinical trials for two proprietary anti-inflammatory drugs: ARRY-797 for pain and ARRY-502 for asthma. ARRY-797 is being tested in a 150-patient Phase 2 chronic pain trial in osteoarthritis (OA) patients with top-line …

and more »

View full post on asthma – Google News

Posted on

Gene scan finds link across array of childhood brain disorders

Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders. With support from the National Institutes of Health, researchers found those mutations through whole exome sequencing — a new gene scanning technology that cuts the cost and time of searching for rare mutations.

View full post on National Institutes of Health (NIH) News Releases